Latest Breaking News On - Sk investment vina iii - Page 1 : comparemela.com

SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.

Republic ofSouth koreaSouth koreanVietnam mother fundService holdingsb vor germanySk groupDragon capital groupFitch solutionsSk group south koreaGeneral meetingNipro pharmaHoldingsb vorSk investment vina iii